Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing.

PubWeight™: 2.31‹?› | Rank: Top 2%

🔗 View Article (PMID 9922409)

Published in Ann Emerg Med on February 01, 1999

Authors

G D Kelen1, J B Shahan, T C Quinn

Author Affiliations

1: Department of Emergency Medicine and the Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA. gkelen@.jhmi.edu

Associated clinical trials:

Rapid HIV Tests for Women Late in Pregnancy and During Labor | NCT00046436

Articles citing this

Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med (2006) 4.86

Point-of-care testing for HIV: HIV counselling and testing. Can J Infect Dis (2002) 2.44

Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med (2008) 1.67

Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. Acad Emerg Med (2008) 1.62

Emergency department patient acceptance of opt-in, universal, rapid HIV screening. Public Health Rep (2009) 1.54

High-volume rapid HIV testing in an urban emergency department. AIDS Patient Care STDS (2009) 1.49

Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Rep (2009) 1.39

Health department collaboration with emergency departments as a model for public health programs among at-risk populations. Public Health Rep (2005) 1.38

Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24

Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med (2008) 1.23

Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests. J Clin Microbiol (2000) 1.19

Emergency department patient perceptions and preferences on opt-in rapid HIV screening program components. AIDS Care (2009) 1.11

Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. Afr Health Sci (2007) 1.11

Video as an effective method to deliver pretest information for rapid human immunodeficiency testing. Acad Emerg Med (2008) 1.10

HIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency Department. Ann Emerg Med (2015) 1.00

Operational methods of HIV testing in emergency departments: a systematic review. Ann Emerg Med (2011) 1.00

Research priorities for human immunodeficiency virus and sexually transmitted infections surveillance, screening, and intervention in emergency departments: consensus-based recommendations. Acad Emerg Med (2009) 1.00

Demographic variations in HIV testing history among emergency department patients: implications for HIV screening in US emergency departments. J Med Screen (2009) 0.97

African American patient experiences with a rapid HIV testing program in an urban public clinic. J Natl Med Assoc (2012) 0.96

Effectiveness of increasing emergency department patients' self-perceived risk for being human immunodeficiency virus (HIV) infected through audio computer self-interview-based feedback about reported HIV risk behaviors. Acad Emerg Med (2009) 0.95

Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center. Public Health Rep (2008) 0.94

Scope of rapid HIV testing in urban U.S. hospitals. Public Health Rep (2008) 0.93

Improvements in the continuum of HIV care in an inner-city emergency department. AIDS (2016) 0.91

Results from a multiple morbidities testing program offering rapid HIV testing bundled with hepatitis and sexually transmitted infection testing. Public Health Rep (2009) 0.90

Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments. Ann Emerg Med (2011) 0.90

Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. Int J Drug Policy (2015) 0.88

Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department. PLoS One (2013) 0.87

Cost of rapid HIV testing at 45 U.S. hospitals. AIDS Patient Care STDS (2010) 0.87

HIV testing and referral to care in U.S. hospitals prior to 2006: results from a national survey. Public Health Rep (2009) 0.85

Can computer-based feedback improve emergency department patient uptake of rapid HIV screening? Ann Emerg Med (2011) 0.85

HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients. R I Med J (2013) (2014) 0.83

Interrelationship of alcohol misuse, HIV sexual risk and HIV screening uptake among emergency department patients. BMC Emerg Med (2013) 0.83

Addressing unmet need for HIV testing in emergency care settings: a role for computer-facilitated rapid HIV testing? AIDS Educ Prev (2013) 0.81

Prevalence and correlates of HIV risk among adolescents and young adults reporting drug use: Data from an urban Emergency Department in the U.S. J HIV AIDS Soc Serv (2014) 0.80

Linkage-to-care Methods and Rates in U.S. Emergency Department-based HIV Testing Programs: A Systematic Literature Review Brief Report. Acad Emerg Med (2016) 0.78

Implementing an HIV Rapid Testing-Linkage-to-Care Project Among Homeless Individuals in Los Angeles County: A Collaborative Effort Between Federal, County, and City Government. Am J Public Health (2015) 0.77

Timing Matters: HIV Testing Rates in the Emergency Department. Nurs Res Pract (2014) 0.75

Preclinical and clinical performance of the Efoora test, a rapid test for detection of human immunodeficiency virus-specific antibodies. J Clin Microbiol (2005) 0.75

The role of emergency department HIV care in resource-poor settings: lessons learned in western Kenya. Int J Emerg Med (2008) 0.75

Articles by these authors

(truncated to the top 100)

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52

Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol (1993) 6.21

AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88

Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15

Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (2000) 5.14

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

Azithromycin in control of trachoma. Lancet (1999) 4.32

Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23

Spread of HIV infection in married monogamous women in India. JAMA (1997) 4.18

Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol (1995) 3.44

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41

Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. BMJ (1995) 3.38

Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18

Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02

Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78

Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68

Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65

Evidence for high prevalence & rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian J Med Res (1996) 2.64

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis (1998) 2.60

The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis (1999) 2.57

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52

Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43

Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39

Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol (1992) 2.36

Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol (1998) 2.35

Epidemiology of hepatitis E virus infection in Turkey. Lancet (1993) 2.29

Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet (1998) 2.29

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J Infect Dis (2000) 2.25

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24

Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol (1997) 2.22

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother (1987) 2.21

Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA (1994) 2.18

Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA (1987) 2.17

Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res (1987) 2.13

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA (1994) 2.11

Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09

Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis (1989) 2.09

The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine (Baltimore) (1995) 2.09

Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol (1998) 2.07

Risk factors and clinical presentation of acute primary HIV infection in India. JAMA (1997) 2.02

Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. J Infect Dis (1990) 1.98

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features. N Engl J Med (1983) 1.97

Enzyme-linked immunosorbent assay for the detection of Giardia lamblia in fecal specimens. J Infect Dis (1984) 1.93

Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86

Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85

Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis (1998) 1.83

Condom use and HIV infection among prostitutes in Zaire. N Engl J Med (1987) 1.82

Screening for Chlamydia trachomatis infection in an inner-city population: a comparison of diagnostic methods. J Infect Dis (1985) 1.81

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78

Substantial increase in human immunodeficiency virus (HIV-1) infection in critically ill emergency patients: 1986 and 1987 compared. Ann Emerg Med (1989) 1.78

Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med (1993) 1.76

Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol (1993) 1.73

Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol (2001) 1.72

Intestinal spirochetosis in homosexual men. Am J Med (1987) 1.72

Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis (2001) 1.70

Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis (2001) 1.66

Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63

Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol (2000) 1.60

Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens. J Clin Microbiol (1990) 1.59

Postabortal endometritis and isolation of Chlamydia trachomatis. Obstet Gynecol (1986) 1.58

Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex Transm Dis (1998) 1.58

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57

In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother (1992) 1.56

A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaïre: is passive surveillance valid? AIDS (1993) 1.55

HIV seroprevalence among hospital workers in Kinshasa, Zaire. Lack of association with occupational exposure. JAMA (1986) 1.54

Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54

Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex Transm Dis (2003) 1.53

Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53

Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52

Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion. Sex Transm Dis (1993) 1.52

Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis (1999) 1.51